Navigation Links
PROMACTA(R) (eltrombopag) RECEIVES UNANIMOUS RECOMMENDATION BY FDA ADVISORY PANEL
Date:5/30/2008

n, affecting less than 200,000 individuals in the United States.(1)

Eltrombopag is an investigational, once-daily oral treatment developed to induce the production of cells in the bone marrow to increase platelets, which are critical in minimizing the incidence of bleeding in chronic ITP.

Eltrombopag, a novel oral thrombopoeitin (TPO) receptor agonist, if approved, would be the first oral short-term treatment of previously treated patients with chronic ITP to increase platelet counts and reduce or prevent bleeding.

In the pivotal studies, the most common adverse events observed in patients taking eltrombopag were headache, nasopharyngitis, and nausea.

About the data

The NDA submission is supported by the largest database of clinical trial information on investigational therapies for chronic ITP patients. Two pivotal trials (one Phase III trial and one Phase II trial), were submitted to support the filing.

About ITP

Chronic ITP is a disorder marked by increased platelet destruction and/or inadequate platelet production in the blood, which causes an increased risk of bruising and bleeding.(2,3) There are estimated to be approximately 60,000 individuals diagnosed with chronic ITP in the U.S.(4) People with chronic ITP often bleed from small blood vessels causing bruises, nosebleeds or even fatal gastrointestinal or intra cerebral bleeds, although these are rare.(3)

About Eltrombopag

Eltrombopag is an oral, non-peptide thrombopoietin receptor agonist that has been shown in pre-clinical research and clinical trials to stimulate the proliferation and differentiation of megakaryocytes, the bone marrow cells that give rise to blood platelets. Eltrombopag was discovered as a result of research collaboration between GlaxoSmithKline and Ligand Pharmaceuticals (Nasdaq:

SOURCE GlaxoSmithKline
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. GlaxoSmithKline Files for FDA Approval of PROMACTA(TM) (eltrombopag) to be the First Oral Platelet Growth Factor for Rare Blood Disorder
2. Lake Elsinore Family Caregiver Receives Free Power Wheelchair From The SCOOTER Store
3. DaVita Receives Civil Complaint
4. Ranbaxy Receives Tentative Approval to Manufacture and Market Galantamine Tablets on an Exclusive Basis
5. Watson Receives First FDA Approval for Manufacturing Product at Its Goa, India Facility
6. Edwards Lifesciences Receives CE Mark for Edwards SAPIEN Transcatheter Heart Valve
7. PainCare Receives $14.4 Million in Cash From Completed Sale of South Florida Ambulatory Surgery Centers
8. UT Southwesterns obesity research receives $22 million NIH Roadmap grant
9. Temple Emergency Medicine receives $1.8M to find best MRSA treatment
10. Prime Therapeutics Receives TIPPS Certification
11. Bioniche Receives $2 Million Government Grant For Market Development Related to its E. coli O157:H7 Cattle Vaccine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2015)... , ... July 28, 2015 , ... ... Total Heart Center at Memorial Regional Hospital, providing expert, streamlined total advanced heart ... be suited to provide extensive heart services under one roof, including the treatment ...
(Date:7/28/2015)... ... July 28, 2015 , ... ... announces Skimmer Helper, a household invention that cleans pools efficiently - minus the ... says Scott Cooper, CEO and Creative Director of World Patent Marketing. "It is ...
(Date:7/28/2015)... Florida (PRWEB) , ... July 28, 2015 , ... ... of patented products, announces Shelled Out, a new household invention that makes shelling ... earn $253.4 billion by 2020,” says Scott Cooper, CEO and Creative Director of ...
(Date:7/28/2015)... ... July 28, 2015 , ... Darryl Worley’s ... volunteers celebrate the 14th year of raising money for the Darryl Worley Foundation. ... for this year’s main concert Saturday, Oct. 3. , This year’s concert will ...
(Date:7/28/2015)... ... ... Morristown Medical Center, part of Atlantic Health System, today announced it was the ... nation, to implant the newly approved CoreValve® Evolut® R System from Medtronic. The system ... , The CoreValve® Evolut® R System was approved by the U.S. Food and Drug ...
Breaking Medicine News(10 mins):Health News:Memorial Cardiac And Vascular Institute Centralizes Cardiac Care Through It's New "Total Heart Center" At Memorial Regional Hospital 2Health News:10 Fascinating Things You Never Knew About Swimming Pools Is Introduced by World Patent Marketing and Skimmer Helper 2Health News:10 Fascinating Things You Never Knew About Swimming Pools Is Introduced by World Patent Marketing and Skimmer Helper 3Health News:10 Fascinating Things You Never Knew About Swimming Pools Is Introduced by World Patent Marketing and Skimmer Helper 4Health News:10 Fascinating Things You Never Knew About Swimming Pools Is Introduced by World Patent Marketing and Skimmer Helper 5Health News:Essential Bang For Your Buck Kitchen Items Presented By World Patent Marketing 2Health News:Essential Bang For Your Buck Kitchen Items Presented By World Patent Marketing 3Health News:Essential Bang For Your Buck Kitchen Items Presented By World Patent Marketing 4Health News:Essential Bang For Your Buck Kitchen Items Presented By World Patent Marketing 5Health News:Worley’s 14th Tennessee River Run Will Host Wade Hayes, Lorrie Morgan, Tracy Lawrence and Others 2Health News:Worley’s 14th Tennessee River Run Will Host Wade Hayes, Lorrie Morgan, Tracy Lawrence and Others 3Health News:Morristown Medical Center First Hospital in New Jersey to Implant Newly Approved Heart Valve 2Health News:Morristown Medical Center First Hospital in New Jersey to Implant Newly Approved Heart Valve 3
... on high alert Wednesday following the first confirmed outbreak of ... thousands of poultry were slaughtered in the Mekong// Delta. ... southern Ca Mau and Bac Lieu provinces, after tests on ... H5N1 strain of avian influenza., ,'We have begun to ...
... conducted by a US research company has highlighted the ... formidable health// problem facing society and their children today. ... 800 adults, found that nearly 27% named 'obesity', as ... insurance followed next with 16% strongly advocating action, ...
... North Carolina at Chapel Hill suggested that low LDL ... ,LDL stands for low density lipoprotein; the low ... Previously associations have been made between LDL and cardiovascular ... Parkinson's disease have a lower occurrence of heart attack ...
... the University of Texas M. D. Anderson Cancer Center suggest ... span of 40 years reduced the tumor growth in the// ... ,The Journal of the National Cancer Institute issued ... drug cromolyn is three times more effective than just the ...
... holding her husband’s hand, says a study. This is indeed ... of marriage// is losing ground. ,A new study ... Virginia, finds that women in a threatening situation show signs ... has been observed in brain scans. ,The researchers, ...
... Andy Kerr will receive Christmas cards from active members ... poor quality of treatment// offered to Chronic Obstructive Pulmonary ... charity suggests that clinical standards be set, to ensure ... ,COPD or Chronic Obstructive Pulmonary Disease is a term ...
Cached Medicine News:Health News:Low LDL Levels Lead to Parkinson's Disease 2Health News:Anti Allergy Drugs Reduce Tumor Growth 2Health News:Anti Allergy Drugs Reduce Tumor Growth 3
(Date:7/28/2015)... Research and Markets ( http://www.researchandmarkets.com/research/cng4gn/refurbished ) has announced the ... Global Forecasts to 2019" report to their offering. ... estimated to grow expected to reach $9.37 billion by ... 2019. Factors such as growing ... increasing privatization in the healthcare sector, and rising adoption ...
(Date:7/28/2015)... July 28, 2015  PD-Rx Pharmaceuticals, Inc., a ... it has partnered with Dobson Technologies, a fully-integrated ... Service (IaaS) product. PD-Rx is an ... the United States.  Using Dobson Technologies, IaaS solution ... business continuity, ensure regulatory compliance, and reduce operating ...
(Date:7/28/2015)... Fla. , July 28, 2015  For many ... their researchers, physicians and other inventors can be a ... market is difficult, and successes are rare. ... wants to change that. Medical Device Investments ... licensed from universities, hospitals and physicians. MDI develops, manufactures ...
Breaking Medicine Technology:Refurbished Medical Equipment Market 2015 - Global Forecasts to 2019 2PD-Rx Partners With Dobson Technologies 2Medical Device Investments To Become Center Of Excellence For The Commercialization Of Innovative Medical Technologies 2
... Texas Children,s Hospital and SynCardia Systems, Inc. announced today ... hospital to complete the first phase of certification to ... intends to use the Total Artificial Heart as a ... heart transplant as children and now require mechanical support ...
... 2011 As the biopharmaceutical marketplace has evolved, leading ... to change as well. Specifically, Market Research is shifting ... shaping strategic objectives for key commercial groups. ... increasingly use new and innovative tools such as Webcams ...
Cached Medicine Technology:Texas Children's Is First Pediatric Hospital To Begin Certification Process for SynCardia's Total Artificial Heart 2Texas Children's Is First Pediatric Hospital To Begin Certification Process for SynCardia's Total Artificial Heart 3Strategic Role Becoming Critical Part of Market Research Function 2
...
...
... At the entry-level, Philips Zymed 1810 Series ... preview, which gives the operator the flexibility ... complex arrhythmia. Choose an application beyond the ... flexibility. Select the interactive or automatic style ...
... Holter Software for Windows is a ... to install, use and maintain as ... comprehensive as a cardiograph., ,Full ... and QuickScan, which combines the benefits ...
Medicine Products: